Kukjeon Pharmaceutical Co., Ltd. logo

Kukjeon Pharmaceutical Co., Ltd. (307750)

Market Open
11 Aug, 03:59
KRX SM KRX SM
2,290. 00
-20
-0.8658%
170.38B Market Cap
- P/E Ratio
40% Div Yield
41,812 Volume
- Eps
2,310
Previous Close
Add Transaction
Day Range
2,210 2,335
Year Range
1,700 6,000
Want to track 307750 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

307750 trading today lower at ₩2,290, a decrease of -0.8658% from yesterday's close, completing a monthly increase of 5.53% or ₩120. Over the past 12 months, 307750 stock lost -31.9465%.
307750 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

307750 Chart

People also search for

Fine M-Tec Co., Ltd.
9,090
-0.7642%
Genexine Co., Ltd.
2,715
-0.1838%
TiumBio Co., Ltd.
4,915
-2.2863%
GeneOne Life Science Inc.
2,670
0%
Iljin Diamond Co. Ltd.
9,250
+0.9825%

Kukjeon Pharmaceutical Co., Ltd. (307750) FAQ

What is the stock price today?

The current price is ₩2,290.00.

On which exchange is it traded?

Kukjeon Pharmaceutical Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 307750.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 40%.

What is its market cap?

As of today, the market cap is 170.38B.

Has Kukjeon Pharmaceutical Co., Ltd. ever had a stock split?

No, there has never been a stock split.

Kukjeon Pharmaceutical Co., Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
KR Country
178 Employees
27 Dec 2024 Last Dividend
- Last Split
- IPO Date

Overview

KUKJEON PHARMACEUTICAL Co., Ltd, established in 1972, positions itself as a comprehensive chemical solutions provider within South Korea. Focusing on a broad array of chemical-based products and services, the company integrates after-sales support including research and development, production, quality control, and Drug Master File (DMF) services into its operations. Standing at the forefront of innovation, KUKJEON PHARMACEUTICAL has secured several patents for its unique manufacturing methods, underlining its commitment to excellence and innovation in the chemical industry. With its headquarters located in Anyang-si, South Korea, the company plays a pivotal role in supplying critical resources across various sectors including pharmaceuticals, intermediate products, new drug synthesis, and related materials industries.

Products and Services

  • Active Pharmaceutical Ingredients (APIs)

    KUKJEON PHARMACEUTICAL specializes in the manufacture of Active Pharmaceutical Ingredients, vital for the production of a wide range of medications. This offering is complemented by molecular design and technical support services, ensuring that partners have access to the highest quality materials backed by expert guidance.

  • Electronic Materials

    The company develops specialized electronic materials including antistatic agents, monomers, and polymers with low dielectric constants, along with UV curing agents. These innovative products find applications in various high-tech industries, demonstrating KUKJEON PHARMACEUTICAL’s capability in bridging chemical solutions with technological advancements.

  • Low-Resistance Electrolyte and Specialty Compounds

    With a focus on the electronics industry, the company produces low-resistance electrolyte solutions, as well as unique phosphine, silane, and boron compounds. These specialized chemicals are essential for the development and manufacture of semiconductors and other critical components.

  • Semiconductor Materials

    Semiconductor materials produced by KUKJEON PHARMACEUTICAL are designed to meet the stringent requirements of the electronic and technology sectors, further solidifying the company's position as a key player in the supply chain of semiconductor manufacturing.

  • Intermediates for Organic Synthesis

    The company provides a diverse range of intermediates such as carbazole, boric acid, and fluorene. These intermediates are crucial for the synthesis of various organic compounds, reflecting the company's vast expertise and innovative capabilities in chemical synthesis.

Contact Information

Address: Geumgang Penterium IT Building
Phone: 82 2 3486 2246